Iomai heeft een nieuwe methode van vaccineren ontwikkeld… transcuttan of te wel met een pleister. De voordelen: geen naalden meer, geen systemisch toedienen van vaccin, en hogere en meer potente vaccins.
Iomai, now part of Intercell, was a new entrant in the field of needle-free vaccination with IP for a patch – based method of dermal delivery. While the start-up was well on its way to developing the pharmaceutical science behind the vaccination, there remained the challenge of prepping the skin to effectively accept the vaccine. The company approached IDEO to develop a viable method of applying a needle-free vaccine delivery patch. The result is a vaccine patch concept and application prototype that consider the complete user experience, from mail-out packaging to application, and has the potential to make self-application possible for the first time.
Reacties